Rekrutierende Studie = ; Fortlaufende Studie = ; Abgeschlossene Studie = ; Förderung durch ein IRDiRC-Mitglied = ; Studie unter Beteiligung von ERN-Mitgliedern aus mindestens zwei Mitgliedstaaten =

Nationale klinische Studie(n)

FRANKREICH

ILE-DE-FRANCE
PARIS

Exo-NMD1: Assessment of Safety and Acute Effects of a Knee-hip Powered Soft Exoskeleton in Patients With Neuromuscular Disorders -FR

Institut de Myologie - Hôpital Pitié-Salpêtrière

Unité clinique de pathologie neuromusculaire

Mehr Details

FRANKREICH

HAUTS-DE-FRANCE
ADDRESS: NOT PROVIDED - FR

Efficacy and safety evaluation of the ExoMS exoskeleton: an innovative impressed 3D upper limb assistive device for children with neuromuscular diseases. A Single-Case Experimental Design trial using Goal Attainment Scaling.

Institution: Information not provided - FR

Mehr Details

JAPAN

JAPAN
ADDRESS : NOT PROVIDED - JP

Multicenter cooperative and investigator initiated clinical trial using valproic acid in childhood onset spinal muscular atrophy : Confirmatory Trial

Institution: Information not provided - JP

Mehr Details

Multinationale klinische Studie(n)

FRANKREICH

HAUTS-DE-FRANCE
ADDRESS: NOT PROVIDED - FR

A Phase 1/2 trial on the safety, tolerability, pharmacokinetics, pharmacodynamics and exploratory efficacy of DYN101 in patients ≥ 16 years of age with centronuclear myopathies caused by mutations in DNM2 or MTM1

Institution: Information not provided - FR

Mehr Details